Andrew Cooper
Stock Analyst at Raymond James
(2.47)
# 2,178
Out of 4,825 analysts
137
Total ratings
45%
Success rate
-1.58%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Reiterates: Outperform | $90 → $71 | $53.10 | +33.71% | 12 | May 2, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $145 → $120 | $94.69 | +26.73% | 8 | Apr 29, 2025 | |
| ITGR Integer Holdings | Maintains: Outperform | $145 → $150 | $124.30 | +20.68% | 2 | Apr 25, 2025 | |
| UFPT UFP Technologies | Initiates: Market Perform | n/a | $210.25 | - | 1 | Mar 28, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $27 → $19 | $7.59 | +150.33% | 4 | Feb 25, 2025 | |
| GH Guardant Health | Reiterates: Outperform | $39 → $59 | $47.52 | +24.16% | 3 | Feb 21, 2025 | |
| AVTR Avantor | Reiterates: Outperform | $26 → $24 | $12.91 | +85.97% | 14 | Feb 10, 2025 | |
| HAE Haemonetics | Reiterates: Strong Buy | $120 → $115 | $64.20 | +79.13% | 8 | Feb 7, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $650 → $667 | $426.11 | +56.53% | 6 | Feb 3, 2025 | |
| DHR Danaher | Downgrades: Market Perform | n/a | $199.95 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $52.20 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $15.66 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $156.59 | -45.72% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $29.20 | +160.27% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.83 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $26.85 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.82 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $30.23 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $45 | $20.18 | +123.05% | 1 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.02 | - | 5 | Sep 22, 2021 |
Hologic
May 2, 2025
Reiterates: Outperform
Price Target: $90 → $71
Current: $53.10
Upside: +33.71%
Revvity
Apr 29, 2025
Reiterates: Outperform
Price Target: $145 → $120
Current: $94.69
Upside: +26.73%
Integer Holdings
Apr 25, 2025
Maintains: Outperform
Price Target: $145 → $150
Current: $124.30
Upside: +20.68%
UFP Technologies
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $210.25
Upside: -
Myriad Genetics
Feb 25, 2025
Reiterates: Outperform
Price Target: $27 → $19
Current: $7.59
Upside: +150.33%
Guardant Health
Feb 21, 2025
Reiterates: Outperform
Price Target: $39 → $59
Current: $47.52
Upside: +24.16%
Avantor
Feb 10, 2025
Reiterates: Outperform
Price Target: $26 → $24
Current: $12.91
Upside: +85.97%
Haemonetics
Feb 7, 2025
Reiterates: Strong Buy
Price Target: $120 → $115
Current: $64.20
Upside: +79.13%
Thermo Fisher Scientific
Feb 3, 2025
Reiterates: Outperform
Price Target: $650 → $667
Current: $426.11
Upside: +56.53%
Danaher
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $199.95
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $52.20
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $15.66
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $156.59
Upside: -45.72%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $29.20
Upside: +160.27%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $3.83
Upside: -
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $26.85
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $7.82
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $30.23
Upside: -
Nov 18, 2022
Initiates: Outperform
Price Target: $45
Current: $20.18
Upside: +123.05%
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $3.02
Upside: -